The crystal structures of the catalytic domain (ÁN1-102/ÁC428-452) of human phenylalanine hydroxylase (hPheOH) in its catalytically competent Fe(II) form and binary complex with the reduced pterin cofactor 6(R)-L-erythro-5,6,7,8-tetrahydrobiopterin (BH 4 ) have been determined to 1.7 and 1.5 A Ê , respectively. When compared with the structures reported for various catalytically inactive Fe(III) forms, several important differences have been observed, notably at the active site. Thus, the nonliganded hPheOH-Fe(II) structure revealed well de®ned electron density for only one of the three water molecules reported to be coordinated to the iron in the high-spin Fe(III) form, as well as poor electron density for parts of the coordinating side-chain of Glu330. The reduced cofactor (BH 4 ), which adopts the expected half-semi chair conformation, is bound in the second coordination sphere of the catalytic iron with a C4a-iron distance of 5.9 A Ê . BH 4 binds at the same site as L-erythro-7,8-dihydrobiopterin (BH 2 ) in the binary hPheOH-Fe(III) ÁBH 2 complex forming an aromatic p-stacking interaction with Phe254 and a network of hydrogen bonds. However, compared to that structure the pterin ring is displaced about 0.5 A Ê and rotated about 10
Introduction
The non-heme iron enzyme phenylalanine hydroxylase (PheOH, phenylalanine 4-monooxygenase, EC. 1.14.16.1) catalyses the hydroxylation of the essential aromatic amino acid L-phenylalanine (L-Phe) to L-tyrosine, which is the rate-limiting step in the complete catabolism of L-Phe. 1 The enzyme belongs to the family of aromatic amino acid hydroxylases with three structurally and functionally closely related enzymes that require the cofactor 6(R)-L-erythro-5,6,7,8-tetrahydrobiopterin (BH 4 ) (Figure 1 ) and dioxygen. 3 In the catalytic reaction the cofactor is oxidized to pterin 4a-hydroxytetrahydrobiopterin. In vivo the latter is then converted to a quinonoid dihydropterin (qBH 2 ) by pterin 4a-carbinolamine dehydratase 4 from which BH 4 is regenerated by a NAD(P)H-dependent dihydropteridine reductase 5 ; quinonoid dihydropterin can alternatively form L-erythro-7,8-dihydrobiopterin (BH 2 ) by isomerization. PheOH is a cytosolic enzyme mainly located in the liver (hepatocytes) which plays an important role in mammalian metabolism by initiating detoxi®cation of high levels of L-Phe. A de®ciency in human phenylalanine hydroxylase (hPheOH) is linked to the autosomal recessive disease phenylketonuria (PKU) 6 , and today more than 400 mutations are known at the hPheOH locus 7 (http:// www.mcgill.ca/pahdb). Although BH 4 is the physiological electron donor in the hydroxylation reaction it is also a potent negative effector of the activation of the enzyme by L-Phe as well as of the phosphorylation of Ser16 by cyclic AMP-dependent protein kinase. 8, 9 The oxidized cofactor (BH 2 ) also inhibits the activation by L-Phe, but at higher concentrations than BH 4 . The dihydroxypropyl side-chain of BH 4 /BH 2 has been found to be essential for this inhibitory effect. 10 ± 12 Substantial progress in elucidating the structure and function of the mammalian aromatic amino acid hydroxylases 3 has been made in the past decade. Crystallographic studies of PheOH and tyrosine hydroxylase (TyrOH) have revealed that they have a common tetrameric architecture and that each of the chains fold into three domains, i.e. a regulatory, catalytic and tetramerization domain. Crystal structures have been determined for dimeric hPheOH catalytic domain at 2.0 A Ê resolution 13 (PDB 1PAH), tetrameric hPheOH catalytic plus tetramerization domains at 3.1 A Ê resolution 14 (PDB 2PAH), hPheOH catalytic domain with bound catechol inhibitors at 2.0-2.15 A Ê resolution 15 (PDB 3PAH, 4PAH, 5PAH and 6PAH), hPheOH catalytic domain in complex with BH 2 at 2.0 A Ê resolution 10 (PDB 1DMW) as well as dimeric rat PheOH regulatory plus catalytic domains in phosphorylated (PrPheOH) (2.2 A Ê resolution) and non-phosphorylated (rPheOH) (2.6 A Ê resolution) states 16 (PDB respectively 1PHZ and 2PHM). Tetrameric rat TyrOH (rTyrOH) catalytic plus tetramerization domains have been determined to 2.3 A Ê resolution 17 (PDB 1TOH) as well as its complex with BH 2 , also to 2.3 A Ê resolution 18 (PDB 2TOH). Although these structures together with sitedirected mutagenesis have signi®cantly improved our understanding of the catalytic and regulatory properties of the enzyme, they have given only partial information on the catalytic mechanism since all the structures relate to the catalytically inactive Fe(III) form of the enzyme and the binary complex with the inactive BH 2 pterin cofactor. In the present study, therefore, we have determined the high-resolution X-ray structures of anaerobic crystals of the catalytically competent reduced form of the dimeric``catalytic domain'' and its complex with the catalytically active form of the pterin cofactor, BH 4 . Our structures differ from the previously determined structures in the overall iron-coordination geometry and conformation of the cofactor bound at the active site.
Results
Overall structure of the reduced catalytic domain of hPheOH, hPheOH-Fe(II)
The reduced dimeric truncated form (residues 103-427) of recombinant hPheOH crystallized in space group C222 1 (a 66.3 A Ê , b 108.4 A Ê , c 124.0 A Ê ) with one monomer per asymmetric unit and a solvent content of 57 %. The ®nal model includes 307 residues, 278 water molecules and the active site iron in the Fe(II) form. That the iron is indeed reduced is supported by three criteria: (i) At the selected anaerobic conditions the active site iron (midpoint potential of 207 AE10 mV for wildtype hPheOH (wt-hPheOH)) 19 is ef®ciently reduced by the high concentration of dithiothreitol (DTT) (midpoint potential of À330 mV) and sodium dithionite (DTN) (midpoint potential À1120 mV); (ii) the active site structure is slightly different from that of the Fe(III) structure including coordinating water molecules (Table 1) ; (iii) in the binary complex the autooxidizable pterin cofactor (BH 4 ) bound at the active site is preserved in its structurally characteristic tetrahydro form (see below and Discussion) and the reduction potential of qBH 2 (174mV) is below that for Fe(III). The hPheOHFe(II) crystal was crystallized similarly, with even higher concentration of reducing agent, as the binary hPheOH-Fe(II) Á BH 4 complex. The structure has been re®ned to a working R-factor of 19.7 % and a free R-factor 25.2 % for all data from 10 to 1.7 A Ê resolution, and there are no outliers in the Ramachandran plot. The overall fold is very similar to the corresponding high-spin (S 5/2) Fe(III) form of the enzyme. 13 However, some interesting differences were observed at the active site where signi®cant electron density was found for only one of the three water molecules coordinated to the iron in the Fe(III) form (see also below for the binary complex) as well as weak and poorly de®ned electron density for C g and the carboxyl group of Glu330 (Figure 2(a) (Figure 2(a) ), but inclusion of these two water molecules gave 2F o À F c density at the noise level and B-factors of 66.2 and 37.8 A Ê 2 , respectively. Thus, only Wat3 was included in the ®nal model. Similar results were obtained with a 2.0 A Ê data set from a crystal that was produced anaerobically by using 30 mM DTN as the reducing agent (data not shown). Several data sets on crystals without reducing agent all revealed strong electron density for all three coordinated water molecules (data not shown) as previously observed. 13 Overall structure of the binary hPheOHFe(II) ÁBH 4 complex
The truncated form (residues 103-427) of the reduced hPheOH co-crystallized with BH 4 in space group C222 1 (a 66.4 A Ê , b 108.5 A Ê , c 124.4 A Ê ) with one monomer per asymmetric unit and a solvent content of 57 %. The rod-shaped crystals formed were slightly different from those without bound cofactor. The ®nal model includes 307 residues, 393 water molecules, the active site iron in the ferrous form (see above) and the cofactor in its reduced form. It has been re®ned to a working R-factor of 15.7 % and a free R-factor 20.3 % for all data from 10 to 1.5 A Ê resolution, and there are no outliers in the Ramachandran plot. The overall fold is very similar to the corresponding ligand-free form of the enzyme 13 and BH 4 binds in the second coordination sphere of the iron (Figure 3 ). In marked contrast to the ligand-free Fe(II) form, the hPheOH-Fe(II) ÁBH 4 complex has well de®ned electron density for Glu330 and for all three water molecules (Wat1-3; Figure 2 )). The pterin ring is approximately planar except for C6, which is about 0.6 A Ê out of the plane, con®rming that the bound cofactor has been successfully kept in the reduced state 22, 23 since the oxidized form, BH 2 , is strictly planar. 24 Superposition of the structure on the hPheOH-Fe(III) ÁBH 2 complex 10 (PDB 1DMW) shows that the reduced cofactor is displaced about 0.5 A Ê in the direction away from Ser251, and that the pterin ring is rotated about 10 (along the C4a-C8a bond) with the pyrimidine ring rotated towards Phe254. Furthermore, the dihydroxypropyl group has a completely different conformation. The torsion angle between the hydroxyl groups in the binary hPheOH-Fe(III)ÁBH 2 complex is about 53 , versus À65 in the binary hPheOH-Fe(II) ÁBH 4 complex and versus À60 in hPheOH-Fe(III)ÁBH 2 as determined by NMR. 25 This enables the BH 4 O2
H to make a strong hydrogen bond (2.4 A Ê ) with the side-chain oxygen of Ser251, while O1 H forms water-mediated hydrogen bonds to residues Ala322 and Glu330 (Table 2, Figure 4 ). In addition, Glu330 adapts a completely different conformation ( Figure 6 ). The coordination of Glu330 is still monodentate, but C g is displaced by 1.4 A Ê , and the coordinating C e is displaced about 1.0 A Ê compared to the crystal structures of non-liganded hPheOHFe(III) and the binary hPheOH-Fe(III) ÁBH 2 complex. Leu255 adapts the same conformation as in the binary complex hPheOH-Fe(III) ÁBH 2 , which is different from the non-liganded structure, forming two hydrophobic contacts with C3
H at a distance of 3.7 A Ê . C3
H and C2 H interacts with Ala322 C 
Distances in parentheses are for the crystal structure of the binary hPheOH-Fe(III) ÁBH 2 complex. 10 Glu330 O e1 is the noncoordinating oxygen.
a Water molecules liganded directly to iron.
( Figure 4 ) at distances of 3.8 A Ê . Leu248 is in a different conformation to that in the binary hPheOH-Fe(III) ÁBH 2 , with C g1 3.7 A Ê from the pterin ring. Some additional conformational changes are observed upon binding of BH 4 when compared to the non-liganded Fe(III) structure. 13 Residues 245-250 are closer to the iron with a maximum displacement (main chain) of 1.5 A Ê for Gly247 C a . The 380's loop 13 is also slightly displaced with a maximum movement at Thr378 C a of 1.0 A Ê . Many of the BH 4 contacts with the enzyme are, however, similar to those reported for the binary hPheOH-Fe(III) ÁBH 2 structure, e.g. the hydrogen bonding network of the pterin ring as described in Figure 4 and Table 2 , and the p-stacking interactions with Phe254. However, several additional water-mediated hydrogen bonds were observed in the hPheOH-Fe(II) ÁBH 4 structure, probably due to the higher 1.5 A Ê resolution.
Discussion
Changes in the coordination of the catalytic iron on reduction Most structural and spectroscopic studies to date on PheOH have focused on different ferric forms of the enzyme since they are experimentally more accessible. 3, 26 However, from a functional point of view structural information on the catalytically competent ferrous form is even more relevant. So far, only magnetic circular dichroism (MCD) and X-ray absorption spectroscopic (XAS) studies on the wild-type rPheOH-Fe(II) form have been performed and interpreted in terms of a six-coordinated distorted octahedral geometry. 27 The iron coordination in the reduced form was reported to be not``drastically'' different from that of PheOHFe(III). The active-site iron in PheOH-Fe(III), as isolated, has electron paramagnetic resonance (EPR) signals characteristic of high-spin (S 5/2) ferric iron, 19, 28, 29 which disappear under catalytic turnover conditions. Although a prereduction of the active-site iron is an obligate step prior to catalysis 30 relatively little is known about the mechanism of this reduction. 26 Reduction of rPheOHFe(III) by 6-methyl-5,6,7,8-tetrahydropterin (or under anaerobic conditions by DTN) causes a decrease in the high-spin g 4.3 EPR signal of the oxidized enzyme, 29 ± 31 and interestingly, DTNreduced rPheOH has been reported to be kinetically indistinguishable from the 6-methyl-5,6,7,8-tetrahydropterin prereduced enzyme. 26, 31 In the recombinant catalytic domain of hPheOH used in the present study the high-spin Fe(III) form has been found by EPR spectroscopy to have a more homogenous iron coordination geometry than in e.g. the rat liver enzyme 29 and in recombinant wt-hPheOH. 19 In the present crystal structure reduced, catalytically competent enzyme was obtained by anaerobic reduction with DTT or DTN. The structure revealed that the six-coordinated iron observed in the hPheOH-Fe(III) form 13 is less apparent in the reduced form with well de®ned electron density only observed for the most tightly bound axial water molecule (Wat3). However, weak omit density is present for Wat1 and Wat2 (Figure 2(a) ) implying that, in spite of the high concentration of DTT the structure may contain traces of Fe(III) or of a six-coordinate Fe(II) form. Interestingly, Wat1 and Wat2 are also absent in P-rPheOH 16 (PDB entry 2PHZ) which also has an``orthorhombic'' iron with the ligands Wat1 and Wat2 missing. However, it should be noted that this structure is solved to a lower resolution (2.2 A Ê ). Furthermore, the Fe(II)-hPheOH structure implies a displacement and possible disorder for Glu330, which cannot be ®tted completely into the observed density (Figures 2(a) and 6) . The Feligand distances and geometry also slightly changed upon reduction, with longer iron distances for Wat3 and the liganding Glu330 O e (Table 1) . However, no signi®cant change was observed in the overall protein fold. Both the present Fe(II) forms belong to space group C222 1 , with cell dimensions similar to all previous crystal structures of double truncated hPheOH 10, 13 so that structural changes must be due to biochemical rather than crystal packing effects. Thus, the only signi®cant change that occurs in hPheOH on reduction of the iron centre is a reduced af®nity for two of the coordinated water molecules, displacement of Glu330 and possible disorder of its side-chain.
Binding of the reduced pterin cofactor
Previous studies on the double truncated form of hPheOH-Fe(III) have shown that the oxidized cofactor BH 2 binds at the active site by an induced ®t mechanism, involving a small conformational change in the protein at the active site 10 as well as in the dihydroxypropyl side-chain of the cofactor. 10, 25 A similar conclusion is reached in the present study on the binding of the reduced cofactor BH 4 to the Fe(II) form of the enzyme (Figure 4) . The side-chain of Leu255 in hPheOH-Fe(II) ÁBH 4 is moved compared to the ligand-free structures of hPheOH adapting the same conformation as in hPheOH-Fe(III) ÁBH 2 . C3
H makes two hydrophobic contacts of 3.7 A Ê with C g and C d of this residue plus one contact of 3.8 A Ê with Ala322 C b . Leu248 adopts a different conformation compared to the binary hPheOH-Fe(III)Á BH 2 , packing C g1 3.7 A Ê away from the pterin ring. Re-orientation of the dihydroxypropyl side-chain enables the O2 H to make a strong hydrogen bond (2.4 A Ê ) with the side-chain oxygen of Ser251, whereas O1
H forms water-mediated hydrogen bonding to residues Ala322 and Glu330. The torsion angles between the hydroxyl groups in both the hPheOHFe(III)Á BH 2 (53 ) and the hPheOH-Fe(II) ÁBH 4 (À65 ) complexes are different from the theoretical structure of BH 4 , which suggests two different forms with angles of À164 and 176 , respectively. 23 A torsion angle of about À60 was found in PheOH-bound BH 2 by NMR. 25 The orientation of the pterin ring system in the present BH 4 structure and the previous BH 2 structure 10 are not the same as that in the NMR and computer modeling structure. 25 Thus, Glu286 does indeed form two water-mediated hydrogen bonds to the ring system, but these are to O4 and N3 ( Figure 4 and Table 2 ) rather than the guanidinium N2 and N3 as suggested by NMR. The same is true of the cofactor-Fe distances with Fe-N5 at 5.7 A Ê , Fe-O4 at 3.8 A Ê and Fe-C4a at 5.9 A Ê , rather than 4.4, 2.6 and 4.3 A Ê , respectively, in the NMR and computer modeling structure. Thus, our study shows that BH 4 is not directly coordinated to the iron.
All present crystal structures of PheOH and TyrOH contain a metal ion with up to six ligands, namely two histidine residues, one glutamic acid and one to three water molecules. Together with the metal ion the two histidine residues and Wat3 are almost identically positioned in all these structures. However, there is considerable variation in the orientation of Glu330 and the presence of Wat1 and Wat2. Coordination geometries for the hPheOH structures are given in Table 1 . Glu330 seems to adopt two different conformations in the aromatic amino acid hydroxylases. The crystal structures reveal that the conformation in hPheOH-Fe(II) ÁBH 4 is, with some variation, similar to that observed in rTyrOH-Fe(III) 17 , the binary rTyrOH-Fe(III) ÁBH 2 18 and P-rPheOH-Fe(III). 16 The other conformation is observed in hPheOHFe(III) 13 , hPheOH-Fe(III)ÁBH 2 10 and the present hPheOH-Fe(II) structure, although in the latter case the side-chain is poorly de®ned. The ligand Wat3, which is present in all PheOH and rTyrOH structures reported so far, is hydrogen bonded to the essential Glu286 (Glu332 in TyrOH). This glutamate plays an important role in binding of BH 4 through two water-mediated hydrogen bonds (O e1 -
Wat4-N3 and O

e2
-Wat3-O4) (Figure 4 ), which has been con®rmed by site-directed mutageneses in wt-PheOH 32 and the double truncated form used in the present study. 10 When present, the ligand Wat1 is consistently hydrogen bonded to Tyr325, which is also involved in BH 4 /BH 2 binding via this water-mediated hydrogen bond to the pterin O4 (Figure 4) . However, Wat1 is absent in P-rPheOH and in the present hPheOH-Fe(II) structure. The ®nal ligand, Wat2, is also absent in hPheOH-Fe(II) and in rPheOH-Fe(III). In the hPheOH-Fe(II) ÁBH 4 structure Wat2 is hydrogen bonded (2.9 A Ê ) to a well de®ned water molecule, Wat5, which lies 3.2 A Ê away from C4a of BH 4 and in the correct direction for electrophilic attack of the cofactor. Although only hydrogen bonded, the Wat2 Wat5 pair (Figure 7 ) is immediately reminiscent of the oxygen binding site proposed in the NMR and computer modeling structure study. 25 It is also interesting to note that if the phenylalanine binding site proposed in the NMR and computer modeling structure 25 is correct, Wat2 is conveniently placed for attack on the C3-C4 bond in the phenyl ring (Wat2-C3 and Wat2-C4 distances 3.0 and 2.8 A Ê , respectively) and, although 3.2 A Ê away, Wat5 is in the correct direction for attack on C4A in the pterin ring.
Fuctional implications
The physiological cofactor, BH 4 , has both a catalytic and a regulatory function in PheOH. 30 The enzyme also requires a non-heme iron, and stoichiometric reduction of the iron centre by the cofactor is a prerequisite for catalysis. 26 In addition, binding of the cofactor to the active site induces a conformational transition 10 that results in an inhibited state of the holo-enzyme. This state is characterized by an inhibition of the phosphorylation of Ser16 in the regulatory domain by cyclic AMPdependent protein kinase and an increase in the concentration of L-Phe required for the several-fold catalytic activation of the tetrameric wild-type enzyme. 8 A recent EPR study 19 has also shown that binding of the oxidized cofactor (BH 2 ) at the active site of hPheOH-Fe(III) results in the appearance of a less rhombic high-spin ferric iron. Potentiometric titrations with subsequent EPR monitoring revealed that the midpoint potential for the catalytic iron in wt-hPheOH was reduced from 207(AE10) mV to 110(AE20) mV on binding BH 2 . This $100 mV reduction in the midpoint potential was interpreted in terms of a change in the iron coordination environment. 19 The present structure of hPheOH-Fe(II) ÁBH 4 shows that the octahedral arrangement around the iron becomes almost perfect, due to displacement of Glu330 (Table 3 , Figure 6 ), from its position in the binary hPheOHFe(III)Á BH 2 10 complex and its ligand-free form. 13 The iron geometry is consistent with the magnetic circular dichroism (MCD) studies of the resting``Tstate'' of the ferrous form upon addition of the reduced pterin, 33 suggesting that the binary hPheOH-Fe(II) ÁBH 4 complex lacks an open coordination position which would allow the formation of a highly reactive oxygen intermediate. In the presence of both substrate and cofactor MCD has indicated a square-pyramidal ferrous site 33 implicating the iron in the coupled hydroxylation and suggesting that a highly reactive oxygen intermediate can only be generated after the binding of both substrate and pterin cofactor.
A theoretical calculation using the perturbative Becke-Perdew model (pBP/DN**) 34, 35 of the PC SPARTAN PRO programme package was performed for the hydroxylated cofactor (4a-hydroxytetrahydrobiopterin) and superpositioned on BH 4 in the binary complex presented here. The distance between the oxygen incorporated in the cofactor and the iron was measured to 6.0 A Ê , which is too long for the formation of a Fe(II)-m-peroxo-BH 4 intermediate that has been proposed during the activation of dioxygen in TyrOH. 36 However, only minor adjustments of the crevice structure or cofactor binding site in the ternary complex (i.e. under turnover conditions) could alter this distance. A change in the binding site of the cofactor seems unlikely due to the strong network of hydrogen bonds and hydrophobic interactions, which also is supported by the relatively low B-factors and unambiguous electron density of the cofactor. However, activation by substrate (L-Phe) binding involves a global conformational change of the enzyme 3,37 as well as in the active site crevice structure as observed for the pterin cofactor binding, implying a possible bridging of molecular oxygen between C4a and the iron. The conformational Figure 7 . Stereo picture of the active site of the binary hPheOH-Fe(II)ÁBH 4 structure plus L-Phe from the (superimposed) ternary hPheOH-Fe(III) ÁBH 2 ÁL-Phe NMR structure. 25 The Figure shows the Wat2 Wat5 pair reminiscent of the oxygen binding site proposed for the ternary structure. 25 The Figure was prepared using MOLSCRIPT. 25 The iron ligand Glu330 adapts a completely different conformation in hPheOH-Fe(II) ÁBH 4 ( Figure 6 ), displacing the C g by 1.4 A Ê and the coordinating O e by 1.0 A Ê as compared to the crystal structures of the binary hPheOH-Fe(III)ÁBH 2 complex 10 and its ligand-free form. 13 Carboxylate shifts have been observed for other enzymes including the di-iron enzymes ribonucleotide reductase 38, 39 and methane monooxygenase 40 , and it has been shown that conformations of carboxylate ligands vary with the oxidation state of the metals. Carboxylate shifts are believed to be the key features for understanding the oxygen activation mechanism in ribonucleotide reductase 41, 42 and methane monooxygenase. 40 We therefore strongly believe that the carboxylate shift of Glu330 and the disorder/mobility of this side-chain are particularly important for the oxygen activation.
Evidence for only one pterin cofactor binding site
In addition to its catalytic function, the pterin cofactor BH 4 also functions as a potent negative effector that inhibits L-Phe activation by forming a binary enzymeÁBH 4 complex. 43 BH 4 binds with high af®nity, 8, 43 and on the basis of pre-steadystate and steady-state catalytic behaviour of rPheOH it has been proposed that the inhibitory effect is mediated by its binding to a second, regulatory site different from the active site. 43 Furthermore, on the basis of crystal structure analyses of a dimeric C-terminal truncated form of rPheOH with catalytic and regulatory properties of the wild-type enzyme, a cofactor binding site in the regulatory domain, distant from the active site, has also been proposed. 16, 44 However, no signi®cant structural evidence has so far been presented in support of such a binding site. 3, 11 On the contrary, the crystal structure analysis of the binary hPheOHFe(III)Á BH 2 complex has revealed that pterin binding to the active site induces localised conformational changes in the crevice structure as well as in the pterin molecule. 10 Furthermore, superposition of this binary complex onto the crystal structure of the ligand-free dimeric rPheOH, 16 which contains both the regulatory and catalytic domains, revealed that the C2
H -OH group of BH 2 is suf®-ciently close (2.7 A Ê ) to form hydrogen bonds to Ser23. 10, 11 The present study has con®rmed this observation and has given additional information on the substantial conformational changes that occur at the active site in response to BH 4 binding, notably at the iron ligand Glu330, which adapts a completely different conformation from that in the non-liganded form of the enzyme.
Materials and Methods
Crystallization and data collection
The double truncated mutant (ÁN1-102/ÁC428-452) of hPheOH was expressed and puri®ed, 45, 46 and crystals were grown using some modi®cations to the previously described method. 47 The hanging-drop vapour-diffusion technique was used with anaerobic conditions (N 2 atmosphere) in a glove box. Reservoir solutions (20 % (w/v) PEG 2000, 10 % (v/v) ethylene glycol and 0.12 M Na-Hepes pH 6.8) were¯ushed with N 2 through a microporous gas distributor, and solid DTT or sodium DTN was subsequently dissolved in the reservoir solution to a concentration of 200 mM (DTT) and deoxygenated. 5 ml of the protein solution (5.5 mg/ml) in 20 mM Na-Hepes (pH 6.8), 75 mM NaCl were mixed with an equal volume of the anaerobic reservoir solution. The crystallization tray with 625 ml reservoir solution was sealed by high vacuum grease and stored in the anaerobic glove box. For the crystallisation of the binary hPheOH-Fe(II) Á BH 4 complex, the reservoir included 10 mM BH 4 and 150 mM DTT was used. Crystal growth was complete within four days. Crystals were selected and¯ash frozen in liquid nitrogen directly from the drop, the whole operation being carried out in the glove box. The crystals without cofactor were thin plates with approximate dimensions 0.5 mm Â 0.2 mm Â 0.05 mm, whereas the crystals of the binary cofactor complex were rod-shaped with dimensions 0.7 mm Â 0.2 mm Â 0.1 mm.
Diffraction images were collected at 110 K on the Swiss-Norwegian Beamline (BM01) at the European Synchrotron Radiation Facility (ESRF) in Grenoble (France), using a MAR345 Research imaging plate system and a wavelength of 0.873 A Ê . One single crystal was used for each data set. An additional separate data set comprising data between 10 and 2.54 A Ê was collected on the hPheOH-Fe(II) Á BH 4 (DTT) crystal using a longer crystal to detector distance and shorter exposure time, with the aim of reducing the background and saturation for the low-resolution data. The data were integrated using the programme DENZO, 48 while the scaling and merging were performed using SCALA from the CCP4 program suite (Collaborative Computational Project, Number 4, 1994) . The statistics for the data sets are presented in Table 4 .
Model building and refinement
The coordinates for the crystal structure of the catalytic domain of hPheOH-Fe(III) 13 (PDB 1PAH) were used as the starting model and for calculating initial phases for both structures. The re®nement was initiated by rigid-body re®nement and simulated annealing methods using CNS version 1.0. 54 Further re®nement was performed using SHELX-97 55 and the peptide-chain was adjusted manually with the aid of the graphical display programme O. 56 The electron density maps used for the manual adjustments were s-weighted, 51 2F obs À F calc and F obs À F calc calculated by SHELX-97. 10 % of the data were excluded in the re®nement for cross-validation. 49 Water molecules were added gradually in positions with F obs À F calc density exceeding 4 s and 2F obs À F calc density exceeding 1.7 s at hydrogen-bonding distances (2.3-3.4 A Ê distance from an oxygen or a nitrogen). Water oxygen atoms with B-factors higher than 63 A Ê 2 were removed prior to the next re®nement round. The iron and all its ligands were omitted early on in the re®ne-ment to ensure that their positions were unbiased. A theoretical calculation of BH 4 using the perturbative Becke-Perdew model (pBP/DN**) 34, 35 of the PC SPAR-TAN PRO programme package was performed making the basis for the cofactor restraints concerning bond lengths and 1,3-distances. The theoretical structure matched the electron density impressively even prior to any re®nement. The higher resolution of the hPheOHFe(II) Á BH 4 (DTT) complex made it possible to re®ne the structure with anisotropic B-factors for all non-hydrogen atoms in the protein and the cofactor. B-Factors for the hPheOH-Fe(II) (DTT) structure were kept isotropic, but the re®nement was performed using an overall anisotropic correction. Side-chain atoms outside 1.5 s 2F obs À F calc density were given occupancy zero, and double conformations were included for some sidechains in the latter re®nement rounds. The ®nal models gave R-factors of 15.7 and 19.7 % for the hPheOHFe(II) Á BH 4 (DTT) and the hPheOH-Fe(II) (DTT) structures, respectively. The better quality of the re®ned hPheOH-Fe(II) Á BH 4 (DTT) structure is most probably due the anisotropic B-factors, larger volume of the crystals and the separate low-resolution data set collected.
Protein Data Bank accession numbers
Atomic coordinates and structure factors have been deposited at the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, with accession numbers 1J8T for the hPheOH-Fe(II) structure and 1J8U for the hPheOH-Fe(II) ÁBH 4 binary complex, respectively. The coordinates will remain privileged until 2002-05-22. 
